Plasma 25-hydroxyvitamin D and Regulation of the Renin-angiotensin System in Humans

Overview

Journal Hypertension

Date 2010 Mar 31

PMID 20351344

Citations 147

Authors

John P Forman

Jonathan S Williams

Naomi D L Fisher

Affiliations

Soon will be listed here.

Abstract

Vitamin D regulates the renin-angiotensin system (RAS) in experimental animals, but corresponding human data are limited. We examined the relation between plasma 25-hydroxyvitamin D and elements of the RAS in 184 normotensive individuals in high sodium balance; these included circulating levels of plasma renin activity and angiotensin II (Ang II) and the renal plasma flow response to infused Ang II, which is an indirect measure of the intrinsic RAS activity in the kidney. Compared with individuals with sufficient 25-hydroxyvitamin D levels (> or = 30.0 ng/mL), those with insufficiency (15.0 to 29.9 ng/mL) and deficiency (<15.0 ng/mL) had higher circulating Ang II levels (P for trend=0.03). Moreover, those with vitamin D deficiency had significantly blunted renal plasma flow responses to infused Ang II (mean decrease of 115 mL/min per 1.73 m(2) in renal plasma flow versus 145 mL/min per 1.73 m(2) among those with sufficient vitamin D levels; P for trend=0.009). Although plasma renin activity was higher among individuals with insufficient levels of vitamin D, the result was not statistically significant. These data suggest that low plasma 25-hydroxyvitamin D levels may result in upregulation of the RAS in otherwise healthy humans.

Citing Articles

Vitamin D deficiency and secondary hyperparathyroidism in adult Fontan patients.

Loffler F, Garlichs J, Uehlein S, Loffler L, Leitolf H, Terkamp C Int J Cardiol Congenit Heart Dis. 2024; 17:100521.

PMID: 39711772 PMC: 11658070. DOI: 10.1016/j.ijcchd.2024.100521.

Unveiling the Interplay-Vitamin D and ACE-2 Molecular Interactions in Mitigating Complications and Deaths from SARS-CoV-2.

Wimalawansa S Biology (Basel). 2024; 13(10).

PMID: 39452140 PMC: 11504239. DOI: 10.3390/biology13100831.

Cardiometabolic Risk Factors Associated with Magnesium and Vitamin D Nutrients during Pregnancy-A Narrative Review.

Naowar M, Dickton D, Francis J Nutrients. 2024; 16(16).

PMID: 39203767 PMC: 11357465. DOI: 10.3390/nu16162630.

Associations of Vitamin D-Related Biomarkers With Hypertension and the Renin-Angiotensin System in Men and Women.

Wang L, Cook N, Manson J, Gaziano J, Buring J, Sesso H Am J Hypertens. 2024; 37(12):953-961.

PMID: 39120701 PMC: 11565204. DOI: 10.1093/ajh/hpae103.

Vitamin D and its associations with blood pressure in the Chronic Kidney Disease in Children (CKiD) cohort.

Kumar J, Roem J, Furth S, Warady B, Atkinson M, Flynn J Pediatr Nephrol. 2024; 39(11):3279-3288.

PMID: 38970659 DOI: 10.1007/s00467-024-06434-1.

References

Kulah E, Dursun A, Aktunc E, Acikgoz S, Aydin M, Can M . Effects of angiotensin-converting enzyme gene polymorphism and serum vitamin D levels on ambulatory blood pressure measurement and left ventricular mass in Turkish hypertensive population. Blood Press Monit. 2007; 12(4):207-13. DOI: 10.1097/MBP.0b013e32813fa371. View

Miyakoshi H, Aoki T, Hirasawa Y . Immunological effects of 1alpha-hydroxycholecalciferol (1alpha-OH-D3) and its metabolites. Clin Nephrol. 1981; 16(3):119-25. View

Pasco J, Henry M, Nicholson G, Brennan S, Kotowicz M . Behavioural and physical characteristics associated with vitamin D status in women. Bone. 2009; 44(6):1085-91. DOI: 10.1016/j.bone.2009.02.020. View

Wakasugi M, Noguchi T, Inoue M, Kazama Y, Tawata M, Kanemaru Y . Vitamin D3 stimulates the production of prostacyclin by vascular smooth muscle cells. Prostaglandins. 1991; 42(2):127-36. DOI: 10.1016/0090-6980(91)90072-n. View

Wark J, Larkins R, Eisman J, Wilson K . Regulation of 25-hydroxy-vitamin D-1 alpha-hydroxylase in chick isolated renal tubules: effects of prostaglandin E2, frusemide and acetylsalicylic acid. Clin Sci (Lond). 1981; 61(1):53-9. DOI: 10.1042/cs0610053. View

London G, Guerin A, Verbeke F, Pannier B, Boutouyrie P, Marchais S . Mineral metabolism and arterial functions in end-stage renal disease: potential role of 25-hydroxyvitamin D deficiency. J Am Soc Nephrol. 2007; 18(2):613-20. DOI: 10.1681/ASN.2006060573. View

Shoback D, Williams G, Moore T, Dluhy R, Podolsky S, Hollenberg N . Defect in the sodium-modulated tissue responsiveness to angiotensin II in essential hypertension. J Clin Invest. 1983; 72(6):2115-24. PMC: 437052. DOI: 10.1172/JCI111176. View

Dobnig H, Pilz S, Scharnagl H, Renner W, Seelhorst U, Wellnitz B . Independent association of low serum 25-hydroxyvitamin d and 1,25-dihydroxyvitamin d levels with all-cause and cardiovascular mortality. Arch Intern Med. 2008; 168(12):1340-9. DOI: 10.1001/archinte.168.12.1340. View

Zhang Z, Sun L, Wang Y, Ning G, Minto A, Kong J . Renoprotective role of the vitamin D receptor in diabetic nephropathy. Kidney Int. 2007; 73(2):163-71. DOI: 10.1038/sj.ki.5002572. View

10.

Burgess E, Hawkins R, Watanabe M . Interaction of 1,25-dihydroxyvitamin D and plasma renin activity in high renin essential hypertension. Am J Hypertens. 1990; 3(12 Pt 1):903-5. DOI: 10.1093/ajh/3.12.903. View

11.

Alroy I, Towers T, Freedman L . Transcriptional repression of the interleukin-2 gene by vitamin D3: direct inhibition of NFATp/AP-1 complex formation by a nuclear hormone receptor. Mol Cell Biol. 1995; 15(10):5789-99. PMC: 230831. DOI: 10.1128/MCB.15.10.5789. View

12.

Duprez D, De Buyzere M, De Backer T, Clement D . Relationship between vitamin D3 and the peripheral circulation in moderate arterial primary hypertension. Blood Press. 1994; 3(6):389-93. DOI: 10.3109/08037059409102292. View

13.

Hypponen E, Boucher B, Berry D, Power C . 25-hydroxyvitamin D, IGF-1, and metabolic syndrome at 45 years of age: a cross-sectional study in the 1958 British Birth Cohort. Diabetes. 2007; 57(2):298-305. DOI: 10.2337/db07-1122. View

14.

Landin-Wilhelmsen K, Wilhelmsen L, Wilske J, Lappas G, Rosen T, Lindstedt G . Sunlight increases serum 25(OH) vitamin D concentration whereas 1,25(OH)2D3 is unaffected. Results from a general population study in Göteborg, Sweden (The WHO MONICA Project). Eur J Clin Nutr. 1995; 49(6):400-7. View

15.

Smotkin-Tangorra M, Purushothaman R, Gupta A, Nejati G, Anhalt H, Ten S . Prevalence of vitamin D insufficiency in obese children and adolescents. J Pediatr Endocrinol Metab. 2007; 20(7):817-23. DOI: 10.1515/jpem.2007.20.7.817. View

16.

Gannage-Yared M, Chedid R, Khalife S, Azzi E, Zoghbi F, Halaby G . Vitamin D in relation to metabolic risk factors, insulin sensitivity and adiponectin in a young Middle-Eastern population. Eur J Endocrinol. 2009; 160(6):965-71. DOI: 10.1530/EJE-08-0952. View

17.

Li J, Brasier A . Angiotensinogen gene activation by angiotensin II is mediated by the rel A (nuclear factor-kappaB p65) transcription factor: one mechanism for the renin angiotensin system positive feedback loop in hepatocytes. Mol Endocrinol. 1996; 10(3):252-64. DOI: 10.1210/mend.10.3.8833654. View

18.

Li Y, Kong J, Wei M, Chen Z, Liu S, Cao L . 1,25-Dihydroxyvitamin D(3) is a negative endocrine regulator of the renin-angiotensin system. J Clin Invest. 2002; 110(2):229-38. PMC: 151055. DOI: 10.1172/JCI15219. View

19.

Norman A . Minireview: vitamin D receptor: new assignments for an already busy receptor. Endocrinology. 2006; 147(12):5542-8. DOI: 10.1210/en.2006-0946. View

20.

Zhou C, Lu F, Cao K, Xu D, Goltzman D, Miao D . Calcium-independent and 1,25(OH)2D3-dependent regulation of the renin-angiotensin system in 1alpha-hydroxylase knockout mice. Kidney Int. 2008; 74(2):170-9. DOI: 10.1038/ki.2008.101. View